Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$744.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| $250K |
| -67.3% |
| Open the original filing on SEC.gov |
| Jun 12 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷ | 25,000 | $1.50 | $37.5K | +205.3% | Open the original filing on SEC.gov |
| Jan 2 | SPRY | ARS Pharmaceuticals, Inc. | AGRANT◆ | 240,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL◷ | 15,000 | $16.99 | $254.9K | -59.3% | Open the original filing on SEC.gov |
| Jul 1, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷ | 15,000 | $1.50 | $22.5K | +145.4% | Open the original filing on SEC.gov |
| Jun 18, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL◷ | 15,000 | $16.00 | $240K | -66.1% | Open the original filing on SEC.gov |
| Jun 18, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷ | 15,000 | $1.50 | $22.5K | +194.9% | Open the original filing on SEC.gov |